HOME >> BIOLOGY >> NEWS
Historian at NJIT will discuss disseminating scientific knowledge in 19th century

How to reach out and touch someone before the telegraph was even invented, fascinates historian Kevin Gumienny, PhD, a special lecturer in the history department at New Jersey Institute of Technology (NJIT). Gumienny, who specializes in the history of science and technology, will highlight three men of science, the history of print and more, Nov. 19, 2005, at a daylong symposium in Madison.

"I'll focus on how scientific ideas were shared, and explore how people used face-to-face communication, written letters, boxed plants, and prints to disseminate, promote and challenge ideas about the natural world," Gumienny said. Editor's Note: To interview Gumienny, call Sheryl Weinstein, 973-596-3436.

Gumienny's talk will highlight work from 1780-1820 of significant scientific figures and the role of printed material. To be highlighted are Isaac Greenwood III, a Boston dentist who focused on electricity; "Mad" Captain John MacPherson, a Philadelphia privateer and real-estate entrepreneur whose scientific specialties were astronomy and mechanics; Henry Moyes, a popular Scottish lecturer about chemistry and natural history.

Gumienny will also focus on Humphrey Marshall, a botanist, at the center of a network of natural historians and gardeners. Marshall used letters and boxes to exchange, not only knowledge, but also seeds, shrubs, trees, and flowers. "He created a great blend of commerce, patronage, and barter," said Gumienny.

Print also played an essential role in early communication. "It helped advertise the lectures of natural philosophers by providing catalogs and botanical descriptions and helped people learn more about their world," said Gumienny.

Print was, in many ways, the most important way people could obtain information about science. Whether through newspaper columns, pamphlets or assessments circulating in magazines, people could learn about the natural world, Gumienny said.

Gumienny, a specialist in the
'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-5203
New Jersey Institute of Technology
9-Nov-2005


Page: 1 2

Related biology news :

1. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
2. Scientists will discuss creating a culture of sustainability February 19 at AAAS
3. Protecting US crops from terrorist attack to be discussed at 2007 AAAS Annual Meeting
4. Neuroscientist Robert Sapolsky will discuss stress, health, Feb. 17 at AAAS meeting
5. Stanford professor to discuss the ups and downs of team science
6. Paleontologists to discuss gap fossils that link fish and land animals
7. Climate scientists to discuss the chilling consequences of nuclear war
8. Leading scientists gather to discuss developments in infectious disease research
9. Winning the oil endgame in America to be discussed at NJIT forum
10. Scientists discuss new frontiers in single-molecule research at American Chemical Society
11. Academics from around the world to discuss animal welfare

Post Your Comments:
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: